NEU neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Angelman, page-70

  1. 369 Posts.
    lightbulb Created with Sketch. 45
    To the LAY investor (me) if I was a BP going to strike re a T/O then that time is from now. SP is at a lull, they've just gone 3/3 with P2's - the rest is somewhat secondary IMO. The question for me is not will it get to market, but how fast can they get 2591 to market. That it works is surely beyond doubt now. Will an offer be credible enough to discourage mgt from doing the P3's themselves, time will tell I guess. But IMO today was the key day from which point we'll know how serious BP are about buying NEU.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.04
Change
-0.500(3.99%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.45 $12.45 $11.88 $1.226M 101.9K

Buyers (Bids)

No. Vol. Price($)
4 121 $12.02
 

Sellers (Offers)

Price($) Vol. No.
$12.04 507 3
View Market Depth
Last trade - 10.28am 23/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.